Researchers Say PSA Level Before Salvage Radiotherapy May Be Prognostic Biomarker Of Clinical Outcomes

Healio (4/7, DeRosier) reports researchers found in “a secondary analysis of a randomized trial published in JAMA Oncology” that “PSA level prior to salvage radiotherapy may be a prognostic biomarker for clinical outcomes of long-term antiandrogen therapy...